Medicine & Life Sciences
Cyclic GMP
93%
Muscarinic Receptors
87%
Arachidonic Acid
80%
Neuroblastoma
79%
Inositol Phosphates
33%
Inhibitory Concentration 50
32%
Masoprocol
26%
Cyclic AMP
26%
Lipoxygenase Inhibitors
23%
FPL 57231
19%
Catalase
17%
Cholinergic Agents
16%
2,3,5-trimethyl-6-(12-hydroxy-5,10-dodecadiynyl)-1,4-benzoquinone
15%
FPL 55712
15%
4,5-Dihydro-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-amine
14%
Quinacrine
12%
stearic acid
11%
Muscarinic Agonists
11%
Tocopherols
11%
Lipoxygenase
11%
Bromides
11%
Reverse-Phase Chromatography
11%
Guanylate Cyclase
11%
Glutathione Disulfide
10%
Linoleic Acid
10%
Cyclooxygenase Inhibitors
10%
Methylene Blue
10%
Alprostadil
10%
Ibuprofen
10%
Oleic Acid
10%
Prostaglandin-Endoperoxide Synthases
9%
Indomethacin
8%
Oxidation-Reduction
8%
High Pressure Liquid Chromatography
7%
Air
7%
Clone Cells
7%
Antioxidants
6%
Enzymes
4%
Chemical Compounds
Parasympathomimetic Agent
100%
Arachidonic Acid
88%
Pharmacological Metabolism
61%
Inositol Phosphate
33%
Effector
26%
Lipoxygenase Inhibitor
24%
Nordihydroguaiaretic Acid
24%
Arachidonate
22%
Muscarinic Agonist
12%
EC 1.14.99.1 (Prostaglandin-Endoperoxide Synthase) Inhibitor
12%
Quinacrine
11%
Pharmacologic Agent
11%
Retinal
9%
Redox State
9%
Prostaglandin
9%
Linoleic Acid
8%
Oleic Acid
7%
Glutathione
7%
Methylene Blue
6%
Antioxidant Agent
6%
High-Pressure Liquid Chromatography
6%
Bromide
5%
Metabolite
5%
Reduction
3%
Acid
2%